Claudia's story: from suspicion to hope
"My name is Claudia, I am 45 years old. I still remember December 26, 2018: I was on vacation in Salerno with my family for the Christmas season when I noticed something unusual-blood in my urine. At that moment, I immediately ruled out a menstrual cycle and tried to deny the worst thought. But the symptom recurred over the next few days; upon returning to Rome, I contacted my doctor.
The doctor sensed the situation and, without wasting time, prescribed a urinary cytology and ultrasound. Those tests were decisive: the presence of cancer cells in the urine emerged, and an ultrasound showed dilatation of the right renal pelvis. On February 11, 2019, the diagnosis came: high-grade urothelial carcinoma, located in the renal pelvis. Subsequently, a radical nephroureterectomy (removal of kidney and ureter) was performed on May 7, 2019 with histological outcome pT2 - G3 - R0, indicating a completely removed high-grade infiltrating tumor.
Despite initially expressing some uncertainty about the need for chemotherapy, the doctors still recommended adjuvant treatment. From July to September, I received three cycles of Cisplatin and Gemcitabine. In September, follow-ups (chest CT scan, abdomen MRI, urinary cytology) were negative: a sigh of relief at last. However, the disease recurred in March 2020, with new carcinomas in the bladder. After two TURBs (transurethral resections) and six weeks of BCG, the clinical picture still indicated the need for radical cystectomy."
The doctor sensed the situation and, without wasting time, prescribed a urinary cytology and ultrasound. Those tests were decisive: the presence of cancer cells in the urine emerged, and an ultrasound showed dilatation of the right renal pelvis. On February 11, 2019, the diagnosis came: high-grade urothelial carcinoma, located in the renal pelvis. Subsequently, a radical nephroureterectomy (removal of kidney and ureter) was performed on May 7, 2019 with histological outcome pT2 - G3 - R0, indicating a completely removed high-grade infiltrating tumor.
Despite initially expressing some uncertainty about the need for chemotherapy, the doctors still recommended adjuvant treatment. From July to September, I received three cycles of Cisplatin and Gemcitabine. In September, follow-ups (chest CT scan, abdomen MRI, urinary cytology) were negative: a sigh of relief at last. However, the disease recurred in March 2020, with new carcinomas in the bladder. After two TURBs (transurethral resections) and six weeks of BCG, the clinical picture still indicated the need for radical cystectomy."
Reflection: the value of early diagnosis in urothelial carcinoma
Claudia remembers the day of her diagnosis not as a moment of despair, but as the beginning of her journey to recovery, thanks to prompt and appropriate medical actions that enabled her positive course. It is a powerful testimony to how early diagnosis can radically transform the evolution of the disease and offer real hope for a cure.
The story highlights several key points:
- Nonspecific but alarming initial symptoms: hematuria, often misunderstood for cystitis, may instead be the first sign of urothelial carcinoma.
- Importance of early diagnosis: the combination of urinary cytology and ultrasound, followed by histologic confirmation and surgical treatment, proved decisive for a favorable course.
- Role of prompt treatment: early surgery and adjuvant chemotherapy contributed significantly to disease control.
- Hope and resilience: turning a day of diagnosis into a starting point for recovery is a powerful message for patients and family members.
The story highlights several key points:
- Nonspecific but alarming initial symptoms: hematuria, often misunderstood for cystitis, may instead be the first sign of urothelial carcinoma.
- Importance of early diagnosis: the combination of urinary cytology and ultrasound, followed by histologic confirmation and surgical treatment, proved decisive for a favorable course.
- Role of prompt treatment: early surgery and adjuvant chemotherapy contributed significantly to disease control.
- Hope and resilience: turning a day of diagnosis into a starting point for recovery is a powerful message for patients and family members.
Conclusion
Claudia's testimony is a story of pain, but also one of hope and strength: an example that underscores the crucial importance of recognizing symptoms early, undertaking the appropriate diagnostic tests immediately, and taking decisive action in the course of treatment. In the presence of hematuria, suspicion is never a premise of defeat, but can be the beginning of a possible victory.
